期刊文献+

乳腺癌超声特征与组织学分级及Ki-67表达的相关性研究 被引量:6

Relationship between ultrasound appearance and histologic grades and expression of Ki-67 in breast cancer
下载PDF
导出
摘要 目的研究乳腺癌超声特征与病理组织学分级及Ki67表达之间的关系。方法回顾分析经病理证实的104个乳腺癌病变,观察其二维及彩色多普勒超声显像特征,用免疫组织化学方法测定肿瘤标本Ki-67表达情况,并分析乳腺癌超声特征与组织学分级及Ki-67表达的关系。结果(1胲组乳腺癌肿块Ki-67阳性表达率为73.1%(76/104)。(2)82个浸润性导管癌肿块(IDC)中,Ⅲ级IDC肿块直径≥2cm及出现Ⅱ~Ⅲ级血流的比率高于Ⅱ级及Ⅰ级IDC肿块,差异有统计学意义(P〈0.05)。(3)Ki-67阳性表达的乳腺癌肿块直径≥2cm、肿块内有微钙化、有腋窝淋巴结转移等的出现比率高于阴性表达的肿块(P〈0.05)。(4)Ⅲ级IDC肿块的Ki-67阳性表达率高于Ⅱ级和Ⅰ级IDC肿块,差异有统计学意义(P〈0.05)。结论乳腺癌的超声特征可以在一定程度上反映其组织学分级及Ki-67的表达水平。 Objective To study the relationship between ultrasound appearance and histologic grades and expression of Ki-67 in breast cancer. Methods The ultrasound appearances of 104 breast carcinomas confirmed by pathology were analyzed. Immunohistochemical method was used to test the expression of Ki-67 in all the breast carcinomas analyzed the relationship between ullrasound appearance and hislologic grades and expression of Ki-67 in breast cancer. Results ( 1 ) The expression rate of Ki-67 were 73.1% ( 76/104 ). ( 2 ) Among the 82 cases of invasive ductal carcinoma( IDC ), appearance rate of diameter ≥2 cm and Ⅱ -Ⅲ grade flow was higher in m grade IDC than in Ⅱ or Ⅰ grade IDC. ( 3 ) Appearance rate of diameter ≥ 2 cm, microcalcification and axillary lymph node metastasis were higher in Ki-67-positive tumors than in Ki-67-negative tumors ( P 〈 0.05 ). ( 4 ) Expression rate of Ki-67 was higher in Ⅲ grade IDC than in Ⅱ or Ⅰ grade IDC( P〈 0.05 ). Conclusion To some extent, uhrasound appearance can reflect the histotogic grade and expression of Ki-67 in breast cancer.
出处 《国际医药卫生导报》 2012年第9期1211-1214,共4页 International Medicine and Health Guidance News
基金 广东省科技厅计划项目经费资助(2010B080702007)
关键词 乳腺癌 超声特征 组织学分级 KI-67 Breast cancer Ultrasound appearance Histologie grades Ki-67
  • 相关文献

参考文献3

二级参考文献24

共引文献39

同被引文献45

  • 1Goldhirsch A, Wood WC, Coates AS, et al. Strategies for sub- types-dealing with the diversity of breast cancer: highlights of the St Galien International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [ J] . Ann Oncol, 2011, 22 (8): 1736-1747. 被引量:1
  • 2Gerdes J, Schuab V, Lemke H, et al. Production of a mouse none-clonal antibody relative with a human nuclear antigen asssociatde with cell proliferation [ J]. Int J Cancer, 1983, 31 (1): 13. 被引量:1
  • 3Baqai T, Sbousba S. Oestrogen receptor negativity as a marker for highgrade ductal carcinoma in situ of the breast [ J] . His-topathology, 2003, 42 (5): 440-447. 被引量:1
  • 4Ross JS, Fletcher JA, Linctte GP, et al. The HER-2/neu gene and prote in cancer 2003 : biomarker and target of thera- py [J] . Oncologist, 2003, 8 (4): 307-325. 被引量:1
  • 5Jiang Qingming,Zhang Hui,Zhang Ping.ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro. Journal of experimental & clinical cancer research : CR . 2011 被引量:1
  • 6Gong P, Wang Y, Liu G, et al. New insight into Ki67 expression at the invasive front in breast cancer[J]. PLoS One, 2013, 8(1) :e54912. 被引量:1
  • 7Urrutice A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer[ J]. J Clin 0ncol,2005,23 (28) :7212-7220. 被引量:1
  • 8de Azambuja E, Cardoso F, de Casrto G Jr, et al. Ki-67 as a prog- nostic marker in early breast cancer: a meta-analysis of published studies involving 12155 patients [ J ]. Br J Cancer, 2007,96 ( 10 ) : 1504-1513. 被引量:1
  • 9Niewiadomska H, Jeziorski A, Olborski B, et al. The expression of the proliferating antigen Ki-67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma[ J]. Exp Clin Cancer Res, 1998,17(4) :503-510. 被引量:1
  • 10张英华.彩色多普勒超声对乳腺肿块的诊断价值[J].中国肿瘤临床与康复,2008,15(1):74-75. 被引量:17

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部